Skip to main content
Log in

A phase II study of cisplatin therapy in recurrent childhood brain tumors

A report from the Childrens Cancer Study Group

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Thirty-six children with brain tumors were treated with surgery, radiation and/or adjuvant chemotherapy. After tumor recurrence, cisplatin (60 mg/m2/day IV×2) was given every three to four weeks. CT scans were used to measure drug response prior to the first, third and fifth courses. Complete and partial responses were demonstrated in nine of 31 evaluable patients. Dose limiting toxicities were renal and auditory. Seven patients developed the syndrome of inappropriate antidiuretic horm one secretion. This study confirms that cisplatin is active in a spectrum of brain tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Highby D, Wallace HJ, Albert DJ: Diamminodichloroplatinum in the chemotherapy of testicular tumors. J Urol 112:100–104, 1974

    Google Scholar 

  2. Einhorn LH, Williams SD: The role of cis-platinum in solid tumor therapy. N Engl J Med 300:289–291, 1979

    Google Scholar 

  3. Kamalakar P, Freeman AI, Highby DJ: Clinical response and toxicity with cis-dichlorodiammineplatinum (II) in children. Cancer Treat Rep 61:835–839, 1977

    Google Scholar 

  4. Gaynon P, Baum E, Greenberg L: A phase II trial of cisplatinum diammine dichloride (DDP) (NSC 117825) in refractory childhood tumors. Proc Am Soc Clin Oncol 20:394, 1979

    Google Scholar 

  5. Stewart DJ, Leavens M, Maor M, Fenn L, Luna M, Bonura J, Caprioloi R, Loo T, Benjamin S: Human central nervous system distribution of cis-diamminedichloroplatinum and use of as a radiosensitizer in malignant brain tumors. Cancer Res 42:2474–2479, 1982

    Google Scholar 

  6. Khan AB, D'Souza BJ, Wharam MD, Champion AA, Sinks LF, Woo SY, McCullough DC, Leventhal BG: Cisplatin therapy in recurrent childhood brain tumors. Cancer Treat Rep 66:2013–2020, 1982

    Google Scholar 

  7. Sexauer CL, Khan A, Burger PC, Krischer JP, Van Eys J, Vats T, Ragab AH: Cisplatin in recurrent pediatric brain tumors. A POG phase 11 study. A pediatric oncology group study. Cancer 56:1497–1501, 1985

    Google Scholar 

  8. Diez B, Menges J, Muriel FS: Evaluation of cisplatinum in children with recurrent brain tumors. Cancer Treat Rep 69:911–913, 1985

    Google Scholar 

  9. Sterrett PR, Thompson AM, Chapman AL, Matzke HA: The effects of hyperosmolarity on the blood-brain barrier. A morphological and physiological correlation. Brain Res 77:281–295, 1974

    Google Scholar 

  10. Stewart DJ, Richard MT, Hugenholtz H, Dennery J, Nundy D, Prior J, Montpetit V, Hopkins HS: Penetration of teniposide (VM 26) into human intracerebral tumors. J Neuro-Oncol 2:315–324, 1984

    Google Scholar 

  11. Hasegawa H, Allen JC, Mehta BM, Shapiro WR, Posner JG: Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis. Neurology 29:1280–1286, 1979

    Google Scholar 

  12. Granowetter L, Rosenstock JG, Packer RJ: Enhanced cisplatinum neurotoxcity in pediatric patients with brain tumors. J Neuro-Oncol 1:293–297, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertolone, S.J., Baum, E.S., Krivit, W. et al. A phase II study of cisplatin therapy in recurrent childhood brain tumors. J Neuro-Oncol 7, 5–11 (1989). https://doi.org/10.1007/BF00149372

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00149372

Key words

Navigation